Early-Stage Biotech CDMO Partnering Strategies with Wacker Biotech
- Author
- Life Science Networks
- Published
- Tue 03 Dec 2024
- Episode Link
- https://podcasters.spotify.com/pod/show/life-science-networks/episodes/Early-Stage-Biotech-CDMO-Partnering-Strategies-with-Wacker-Biotech-e2rqs1c
John Childers, Director of Business Development for Wacker Biotech’s North American operations, emphasises the importance of early CDMO partnerships: “Working with an experienced CDMO partner can really help you stay on track for budget and schedule. Think long term – the investment with an external partner can substantially save you time and money.”
As part of Wacker Chemie, a century-old German chemical company, the biotech division leverages over 20 years of experience in advanced therapy manufacturing for contract development and manufacturing.
Speaking to the PharmaSource podcast ahead of CDMO Live 2025, John shares best practices for successful partnerships and explains how Wacker Biotech is positioning itself for growth in the evolving contract manufacturing landscape.
